The EU Medicines Agency could approve AstraZeneca’s COVID-19 vaccine by the end of the month. If it does, it will be the third vaccine to be approved in the EU and Norway.
An application for preliminary market approval is expected next week, the Norwegian Medicines Agency wrote on Twitter on Friday.
“A conclusion could be reached at the end of January, depending on the data and the evaluation process,” it noted.
Approved in the UK
The vaccine has been developed in collaboration with the University of Oxford and has already been approved in the United Kingdom.
In August, the European Commission entered into an agreement to purchase up to 400 million doses of the new vaccine.
Norway is covered by the EU’s vaccine agreements with manufacturers.
Source: © NTB Scanpix / #Norway Today / #NorwayTodayNews